Press Releases
-
MR Solutions receives a Third Queen’s Award for innovative PET imaging technology in pre-clinical scanners
GUILDFORD, UNITED KINGDOM - Jul 30, 2019 - MR Solutions has received the prestigious Queens Award for Enterprise in recognition of the companys innovative PET imaging technology for use in pre-clinical research
Jul 30, 2019
-
Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform
PRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19
Jul 30, 2019
-
TrialScope Taps Industry Veteran as CTO
BURLINGTON, NJ, US - Jul 29, 2019 - TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology Officer
Jul 29, 2019
-
FierceBiotech’s 4th Drug Development Forum Features Executive Leadership Perspectives on R&D Trends, Strategic Planning, and Business Development Strategies in Boston October 28–29
BOSTON, MA, UNITED STATES - Oct 28, 2019 - BOSTON, MA - Convening at the Colonnade Hotel, attendees of the 4th FierceBiotech Drug Development Forum will gain executive-level insights into the end-to-end drug development process, with one track focusing on early R&D, clinical development, through product commercialization
Jul 25, 2019
-
Operations commence at Wasdell Group’s EU headquarters
- Jul 19, 2019 - The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has today announced its new state-of-the-art facility in Dundalk, Ireland has received its Manufacturers / Importation Authorisation licence (MIA) from the Health Products Regulatory Authority (HPRA)
Jul 19, 2019
-
Certara Expands its Drug Evidence & Access Capabilities Through the Addition of Compass Strategic Consulting’s Team
PRINCETON, NJ - Jul 18, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certaras Evidence & Access group
Jul 18, 2019
-
The Pistoia Alliance to Develop a Toolkit to Support Implementation of the FAIR Guiding Principles
BOSTON, MA, UNITED STATES - Jul 17, 2019 - The Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life sciences R&D, today announced the launch of its FAIR Implementation project, backed by pharmaceutical companies including Roche, Astra Zeneca, and Bayer
Jul 17, 2019
-
Rho Announces New Resource for Behavioral and Social Science Researchers to Prepare Research Protocols
DURHAM, NC - Jul 17, 2019 - Rho Announces New Resource for Behavioral and Social ScienceResearchers to Prepare Research ProtocolsCRO facilitated Trans-NIH committee to develop protocol template with NIDCR Research Triangle Park, NC - July 16, 2019 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that Rho's Principal Research Scientist and Program Lead Nancy Yovetich, PhD, and Project Manager Lisa Busko participated in a trans-NIH + extramural committee to develop a standardized protocol template for behavioral and social science researchers
Jul 16, 2019
-
PerkinElmer Launches CE-Marked Infectious Disease Immunoassays on EUROIMMUN Random Access Instrument
WALTHAM, MA, UNITED STATES - Jul 10, 2019 - PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and anti-EBV/EBNA (Epstein-Barr Virus) antibodies on its EUROIMMUN RA Analyzer 10 system
Jul 10, 2019
-
Atlantic Research Group Selects Greenphire to Improve the Patient Experience for its Rare Disease and Oncology Clinical Trials
DEVON, PA, UNITED STATES - Jul 9, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has been selected by Atlantic Research Group (ARG), a rare and neurodegenerative disease, oncology and immunology-focused contract research organization (CRO) to implement its ClinCard and ConneX solutions to improve the clinical trial experience for sites and patients
Jul 9, 2019
-
Under the spotlight: Amgen’s VP for the Center of Observational Research Will Discuss the Role of RWE in a Comprehensive Product Evidence Generation Plan
BOSTON, MA, UNITED STATES - Jul 9, 2019 - Under the spotlight: Amgen's VP for the Center of Observational Research Will Discuss the Role of RWE in a Comprehensive Product Evidence Generation PlanAmidst a (r)evolution in pharmaceutical strategy, Real World Evidence is more than ever a key driver of growing innovation in product life cycle
Jul 9, 2019
-
Certara Announces the Formation of a New Practice Area Focused on Global Health
PRINCETON, NJ - Jul 9, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide
Jul 9, 2019
-
PHARMASEAL Launches Second Major Release of Engility CTMS
NOTTINGHAM, UNITED KINGDOM - Jul 8, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its Engility CTMS platform
Jul 8, 2019
-
Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships
PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
Jun 25, 2019
-
ERT Participates in Groundbreaking, Digital Technology Research
PHILADELPHIA, PA, UNITED STATES - Jun 24, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its involvement in a groundbreaking project to enhance drug development and improve the clinical management of mobility loss
Jun 24, 2019
-
ERT Showcases Scientific and Technological Expertise in Improving Clinical Research at DIA Annual Meeting
PHILADELPHIA, PA, UNITED STATES - Jun 20, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its scientific and technological experts will present a series of innovative and educational live sessions and posters at the 2019 Drug Information Association (DIA) Annual Meeting in San Diego, June 23-27
Jun 20, 2019
-
IDDI IN COLLABORATION WITH ROCHE HAVE IDENTIFIED WHY USING DISEASE FREE SURVIVAL AS A PRIMARY ENDPOINT IN EARLY BREAST CANCER IS THE WAY FORWARD
LOUVAIN-LA-NEUVE, BELGIUM - Jun 20, 2019 - IDDIs findings suggest that it is appropriate to use disease-free survival (DFS) as a surrogate for overall survival (OS) in trials in HER-2-positive, early breast cancer
Jun 20, 2019
-
Shimmer and ClearSky Announce Partnership to Improve Analysis of Wearable Sensor Data for CNS Diseases
CAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
Jun 19, 2019
-
Signant Health Experts Share Benefit of Integrating Patient-Centric Technology Solutions at Global Life Sciences Annual Forum DIA 2019
PHILADELPHIA, PA, UNITED STATES - Jun 18, 2019 - Signant Health (formerly CRF Health and Bracket) will provide expert insights at the forthcoming DIA Global Annual Meeting in San Diego, CA
Jun 18, 2019
-
Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities
WAYNE, PA - Jun 18, 2019 - Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the worlds health, today announced its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to enhance overall data quality oversight and ensure regulatory compliance within clinical trials
Jun 18, 2019
